Additionally, Dangaj et al., using murine and human experimental systems, demonstrated that the initial recruitment of T cells to tumors is driven by tumor-derived CCL5 along with IFNγ-inducible CXCR3 ligands secreted by myeloid cells present in the tumors (54). The gene discussed is CCL5; the disease is neoplasm.